The U.S. Department of Health and Human Services (HHS) issued a proposed rule Nov. 30 to establish the 340B Administrative Dispute Resolution (ADR) process implementing a formal manner for resolving disputed claims. The ADR process would provide a forum for addressing overcharges by drug manufacturers and establish a deadline for ADR panel decisions. The ADR process is critical for ensuring integrity of the 340B program, which is vital for hospitals and the vulnerable patients they serve, particularly given the staffing challenges and unprecedented inflationary increases hospitals continue to experience. The MHA drafted its comments and encourages 340B hospitals to review the proposed rule and submit comments by 5 p.m. Jan. 30. Commenters should include the HHS Docket No. “HRSA-2021-000X” when submitting their letters.
Members with questions should contact Katie Jaskolski at the MHA.